WO2002092063A3 - Verwendung von rutinen und aescinen zur behandlung okulärer durchblutungsstörungen - Google Patents

Verwendung von rutinen und aescinen zur behandlung okulärer durchblutungsstörungen Download PDF

Info

Publication number
WO2002092063A3
WO2002092063A3 PCT/EP2002/005178 EP0205178W WO02092063A3 WO 2002092063 A3 WO2002092063 A3 WO 2002092063A3 EP 0205178 W EP0205178 W EP 0205178W WO 02092063 A3 WO02092063 A3 WO 02092063A3
Authority
WO
WIPO (PCT)
Prior art keywords
aescins
rutins
utilization
treatment
circulatory disturbances
Prior art date
Application number
PCT/EP2002/005178
Other languages
English (en)
French (fr)
Other versions
WO2002092063A2 (de
Inventor
Kailash Kumar Gauri
Original Assignee
Brench Ag
Kailash Kumar Gauri
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brench Ag, Kailash Kumar Gauri filed Critical Brench Ag
Priority to AU2002342288A priority Critical patent/AU2002342288A1/en
Priority to US10/476,484 priority patent/US20050003029A1/en
Priority to EP02750913A priority patent/EP1463514A2/de
Publication of WO2002092063A2 publication Critical patent/WO2002092063A2/de
Publication of WO2002092063A3 publication Critical patent/WO2002092063A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Die vorliegende Erfindung betrifft die Verwendung von Rutinen und Aescinen zur Behandlung okulärer Durchblutungsstörungen. Beschrieben werden auch Mittel mit einer entsprechenden Wirkstoffkombination sowie Mittel in Form von Handelspackungen mit entsprechenden Kombinationspräparaten oder Monopräparaten zur kombinierten Anwendung.
PCT/EP2002/005178 2001-05-10 2002-05-10 Verwendung von rutinen und aescinen zur behandlung okulärer durchblutungsstörungen WO2002092063A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2002342288A AU2002342288A1 (en) 2001-05-10 2002-05-10 Utilization of rutins and aescins in the treatment of ocular circulatory disturbances
US10/476,484 US20050003029A1 (en) 2001-05-10 2002-05-10 Utilization of rutins and aescins in the treatment of ocular circulatory disturbances
EP02750913A EP1463514A2 (de) 2001-05-10 2002-05-10 Verwendung von rutinen und aescinen zur behandlung okulärer durchblutungsstörungen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10122714A DE10122714A1 (de) 2001-05-10 2001-05-10 Verwendung von Rutinen und Aescinen zur Behandlung okulärer Durchblutungsstörungen
DE10122714.0 2001-05-10

Publications (2)

Publication Number Publication Date
WO2002092063A2 WO2002092063A2 (de) 2002-11-21
WO2002092063A3 true WO2002092063A3 (de) 2004-05-27

Family

ID=7684279

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/005178 WO2002092063A2 (de) 2001-05-10 2002-05-10 Verwendung von rutinen und aescinen zur behandlung okulärer durchblutungsstörungen

Country Status (5)

Country Link
US (1) US20050003029A1 (de)
EP (1) EP1463514A2 (de)
AU (1) AU2002342288A1 (de)
DE (1) DE10122714A1 (de)
WO (1) WO2002092063A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT501682A1 (de) 2005-01-14 2006-10-15 Hermine Dr Engl Verfahren zur herstellung einer wirkstoffmischung

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2181454A1 (en) * 1972-04-25 1973-12-07 Nouvel Lucien Synergistic circulatory medicament - combining rutine deriv with escine and vasodilators
DE3432881A1 (de) * 1984-09-07 1986-03-20 Roshdy Dipl.-Chem. Dr. 5000 Köln Ismail Vitamin a + e enthaltende kapsel mit lecithin
WO1998051291A1 (fr) * 1997-05-13 1998-11-19 Remacle Jose Utilisation d'une composition pharmaceutique dans le traitement et/ou la prevention de l'ischemie
WO1999048386A1 (de) * 1998-03-24 1999-09-30 Stueckler Franz Mittel auf der basis von naturstoffen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077534A (en) * 1997-09-02 2000-06-20 Klinge Pharma Gmbh Production of pharmaceutical formulations for treatment of edema and venous disorders
AU1855200A (en) * 1999-12-30 2001-07-16 Shandong Luye Pharmaceutical Co. Ltd. A lower toxicity and anti-inflammatory and anti-exudation pharmaceutical composition
JP2004505046A (ja) * 2000-07-28 2004-02-19 イムファルム・アンパルトセルスカブ 感冒、アレルギー性鼻炎および気道に関連した感染症の症状の処置方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2181454A1 (en) * 1972-04-25 1973-12-07 Nouvel Lucien Synergistic circulatory medicament - combining rutine deriv with escine and vasodilators
DE3432881A1 (de) * 1984-09-07 1986-03-20 Roshdy Dipl.-Chem. Dr. 5000 Köln Ismail Vitamin a + e enthaltende kapsel mit lecithin
WO1998051291A1 (fr) * 1997-05-13 1998-11-19 Remacle Jose Utilisation d'une composition pharmaceutique dans le traitement et/ou la prevention de l'ischemie
WO1999048386A1 (de) * 1998-03-24 1999-09-30 Stueckler Franz Mittel auf der basis von naturstoffen

Also Published As

Publication number Publication date
US20050003029A1 (en) 2005-01-06
AU2002342288A1 (en) 2002-11-25
DE10122714A1 (de) 2002-11-21
EP1463514A2 (de) 2004-10-06
WO2002092063A2 (de) 2002-11-21

Similar Documents

Publication Publication Date Title
WO2004021968A3 (en) Solution for ungual application
WO2001085106A3 (de) Kosmetisches mittel enthaltend 2-furanonderivate
AU2002318419A1 (en) Fabric care composition comprising fabric or skin beneficiating ingredient
CA2348207A1 (en) Disposable diaper
MXPA03005893A (es) Proteccion, restauracion, y mejora de celulas, tejidos y organos que responden a la eritropoyetina.
WO2003032941A3 (de) Kosmetische und/oder dermatologische wirkstoffkombination
WO2002024613A3 (en) Resorcinol derivatives
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
WO2006018454A3 (de) Kosmetische zubereitung mit hyaluronsäure und saponinen zur behandlung von hautalterungserscheinungen
WO2003053180A3 (de) Wirkstoffhaltige unterwäsche
WO2002092040A3 (en) Topical product with visual indicator
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AU2002240463A1 (en) Use of endostatin in the treatment of ocular neovascularization
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
AU2002363973A1 (en) Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
WO2003011241A8 (de) Verwendung von kreatinin und/oder kreatininderivaten in kosmetischen oder dermatologischen zubereitungen
WO2002000208A3 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
WO2002092063A3 (de) Verwendung von rutinen und aescinen zur behandlung okulärer durchblutungsstörungen
AU2001296173A1 (en) 3,8-diazabicyclo(3.2.1)octanes and their use in the treatment of cardiac arrhythmias
CA2338988A1 (en) Aqueous growth-regulating compositions
ZA200110533B (en) Aqueous concentrate pesticidal compositions having improved dermal and ocular safety.
WO2000002579A3 (en) Component b as angiogenic agent in combination with human growth factors
AU3262697A (en) Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
DE50207854D1 (de) Verwendung von rutinen und aescinen zur behandlung aurikulärer durchblutungsstörungen

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002750913

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10476484

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2002750913

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2002750913

Country of ref document: EP